-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from Q4 2020 to Q3 2024.
- Oramed Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2024 was 2.7 %.
- Oramed Pharmaceuticals Inc. annual Return On Equity for 2023 was 3.61 %.
- Oramed Pharmaceuticals Inc. annual Return On Equity for 2022 was -23.6 %, a 18.4% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)